We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tristel Plc | LSE:TSTL | London | Ordinary Share | GB00B07RVT99 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
10.00 | 2.25% | 455.00 | 450.00 | 460.00 | 455.00 | 445.00 | 445.00 | 19,365 | 16:06:07 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Med, Dental, Hosp Eq-whsl | 36.01M | 4.46M | 0.0941 | 48.35 | 215.67M |
TIDMTSTL
RNS Number : 0430P
Tristel PLC
05 February 2019
Tristel plc
("Tristel" or the "Company")
Director Appointment
Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products utilising proprietary chlorine dioxide chemistry, announces the appointment of Dr. Bruno Holthof to its Board as a non-executive director.
Dr. Bruno Holthof is the Chief Executive Officer of Oxford University Hospitals ("OUH"). Before OUH, he was CEO of the Antwerp Hospital Network from January 2004 until September 2015. Bruno Holthof is also Chair of the Board of Armonea, a European private care home provider.
Before becoming a CEO, he was a partner at McKinsey & Company. During this period, he served a wide range of healthcare clients in Europe and the United States and gained significant expertise in the areas of strategy, organisation and operations. He holds an MBA from the Harvard Business School and an MD/PhD from the University of Leuven.
Commenting on the appointment, Paul Swinney, CEO of Tristel, said: "We are delighted to welcome Bruno to our Board. Bruno has more than 10 years of board level experience on publicly listed companies. He also brings to the Board an in-depth knowledge and operational experience of healthcare systems in different markets. We very much look forward to working together."
For further information please contact:
Tristel plc Tel: 01638 721 500 Paul Swinney, Chief Executive Officer Liz Dixon, Finance Director Walbrook PR Ltd Tel: 020 7933 8780 or tristel@walbrookpr.com Paul McManus Mob: 07980 541 893 Lianne Cawthorne Mob: 07584 391 303 finnCap Tel: 020 7220 0500 Geoff Nash/ Giles Rolls (Corporate Finance) Alice Lane (Corporate Broking)
Regulatory disclosure - The following information is disclosed in accordance with Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules for Companies.
Bruno Luc Myriam Holthof, 57, holds nil ordinary shares in the Company and nil options. Dr. Holthof current and previous directorships are as follows:
Current Directorships/Partnerships:
Project Tower Member 2 Limited
Praksis UK Ltd
Shelford Health Roundtable
Oxford University Hospital NHS Foundation Trust
Armonea Group NV
Directorship held in last 5 years:
Barco NV
BPost NV/SA
Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
BOAUSSKRKBAURAR
(END) Dow Jones Newswires
February 05, 2019 02:01 ET (07:01 GMT)
1 Year Tristel Chart |
1 Month Tristel Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions